Press releases 2024

 


Year-end report 2023, January 1-December 31

Regulatory press release

ADDvise delivers its strongest quarter to date and surpasses financial targets for 2023. Net sales increased by 24% and EBITDA amounted to a record SEK 126 million, corresponding to an EBITDA margin of 32%.

Read more

ADDvise receives order worth EUR 2.1 million

Regulatory press release

ADDvise Group’s subsidiary Labplan has received an order from the pharmaceutical company Eli Lilly. The order is worth approximately EUR 2.1 million and involves advanced laboratory instruments for quality control purposes. The instruments will be used in a new manufacturing facility for biologic pharmaceuticals in Limerick, Ireland. Delivery of the order is scheduled to the…

Read more

ADDvise publishes prospectus and applies for admission to trading of bonds on Nasdaq Stockholm

Regulatory press release

On 20 November 2023, ADDvise Group successfully issued senior secured bonds in an amount of SEK 450 million, under a total framework of SEK 2,000 million. Following the bond issue, in total SEK 1,450 million is outstanding under the framework. Pursuant to the terms and conditions for the bonds, ADDvise has undertaken to apply for…

Read more

ADDvise receives order worth USD 2.5 million

Regulatory press release

ADDvise Group’s subsidiary MRC Systems has received an order from SaudiVax. The company is a biotechnology company specialized in the development and production of vaccines and biopharmaceuticals. The order is worth approximately USD 2.5 million and involves design, installation, and commissioning of a cleanroom and associated accessories. The facility is located in the Kingdom of…

Read more